DE2462312A1 - Arzneimittel zur behandlung von migraene-erkrankungen - Google Patents

Arzneimittel zur behandlung von migraene-erkrankungen

Info

Publication number
DE2462312A1
DE2462312A1 DE19742462312 DE2462312A DE2462312A1 DE 2462312 A1 DE2462312 A1 DE 2462312A1 DE 19742462312 DE19742462312 DE 19742462312 DE 2462312 A DE2462312 A DE 2462312A DE 2462312 A1 DE2462312 A1 DE 2462312A1
Authority
DE
Germany
Prior art keywords
lithium
caffeine
migraine
ergotamine tartrate
contg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19742462312
Other languages
English (en)
Inventor
Hans A Dr Med Nieper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PERMICUTAN-KG DR. EULER, 4790 PADERBORN, DE
Original Assignee
NADROL CHEMIE PHARMA KEIZER KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NADROL CHEMIE PHARMA KEIZER KG filed Critical NADROL CHEMIE PHARMA KEIZER KG
Priority to DE19742462312 priority Critical patent/DE2462312A1/de
Publication of DE2462312A1 publication Critical patent/DE2462312A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
DE19742462312 1974-03-04 1974-03-04 Arzneimittel zur behandlung von migraene-erkrankungen Withdrawn DE2462312A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19742462312 DE2462312A1 (de) 1974-03-04 1974-03-04 Arzneimittel zur behandlung von migraene-erkrankungen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742462312 DE2462312A1 (de) 1974-03-04 1974-03-04 Arzneimittel zur behandlung von migraene-erkrankungen

Publications (1)

Publication Number Publication Date
DE2462312A1 true DE2462312A1 (de) 1976-10-14

Family

ID=5934956

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19742462312 Withdrawn DE2462312A1 (de) 1974-03-04 1974-03-04 Arzneimittel zur behandlung von migraene-erkrankungen

Country Status (1)

Country Link
DE (1) DE2462312A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003049730A1 (en) * 2001-12-13 2003-06-19 Magral Limited Treatment of statin side effects using uridine derivatives
EP1343488A1 (de) * 2000-11-29 2003-09-17 Centre For Molecular Biology And Medicine Behandlung der nebenwirkungen von statinen

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1343488A1 (de) * 2000-11-29 2003-09-17 Centre For Molecular Biology And Medicine Behandlung der nebenwirkungen von statinen
JP2004531468A (ja) * 2000-11-29 2004-10-14 マグラル・リミテッドMagral Limited スタチン副作用の処置
EP1343488A4 (de) * 2000-11-29 2005-05-04 Magral Ltd Behandlung der nebenwirkungen von statinen
WO2003049730A1 (en) * 2001-12-13 2003-06-19 Magral Limited Treatment of statin side effects using uridine derivatives
JP4781629B2 (ja) * 2001-12-13 2011-09-28 マグラル・リミテッドMagral Limited ウリジン誘導体を用いるスタチンの副作用の処置

Similar Documents

Publication Publication Date Title
SE7410205L (sv) Stimulatoranordning for inforing i en levande organism.
NL930020I1 (nl) Werkwijze voor het bereiden van een farmaceutisch preparaat geschikt voor gebruik bij de behandelingvan hart- en vaatziekten,alsmede werkwijze voor het bereiden van een gesubstitueerd fenoxy-aminopropanol dat als actieve stof in dat preparaat kan worden opgenomen
NL161461C (nl) Werkwijze voor de bereiding van samenstellingen, die door bestralen met ultraviolet licht polymeriseerbare verbin- dingen of mengsels daarvan alsmede alpha-gesubstitueerde benzoienderivaten bevatten.
ZA8000553B (en) Process for the preparation of tablets with retarded liberation of the active agent,in which tablets the rate of liberation of the active agent is predetermined
ES227824Y (es) Un dispositivo para introducir una composicion acuosa en unacavidad del cuerpo.
GB791487A (en) A milling cutter
NL171446C (nl) Werkwijze voor de bereiding van cardiovasculair werkzame preparaten door een of meer 4-(3,4-dialkoxybenzyl)-2-imidazolidinonen in een voor therapeutische toediening geschikte vorm te brengen, alsmede werkwijze voor de bereiding van de betreffende verbindingen.
NL167151C (nl) Werkwijze ter bereiding van geneesmiddelen met anti-parasitaire werking op basis van halogeen bevatten- de 2,2'-methyleendifenolderivaten, alsmede werkwijze ter bereiding van deze geneeskrachtige verbindingen.
GB1279500A (en) Process for the treatment of tobacco
ES8704712A1 (es) Procedimiento para tratar frutas y hortalizas por termonebu-lizacion
NL170857C (nl) Werkwijze ter bereiding van een therapeutisch preparaat met een kalmerende, rustgevende en de spieren ontspannende werking, alsmede werkwijze ter bereiding van een 6-fenyl-4h-s-triazoloÿ4,3-aÿÿ1,4ÿ benzodiazepine.
IL31250D0 (en) Process for the preparation of salts of hydroxylamine
BE882833A (fr) Sels mixtes d'acides amines essentiels ou semi-essentiels et de leurs analogues exempts d'azote, en utilisant pour traiter des desordres renaux
GB1012928A (en) Ion-exchange process
NO142400B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, nye benzimidazolinon-derivater
CH375450A (de) Verfahren zur Erzeugung eines hochdotierten p-Bereiches und des zugehörigen Kontaktes an einem Halbleiterkörper
CA995864A (en) Method for quickly treating fabrics with liquid ammonia
CA1005757A (en) Aqueous compositions for lumber treatment
ZA7200608B (en) Process for preventing precipitations in water or aqueous solutions
ES409718A1 (es) Procedimiento para el tratamiento de superficies de alumi- nio o de aleaciones de aluminio.
CA966980A (en) Method of treating nitrogen oxide generating substances by combustion
NL163527C (en) Method and device for continuously and against treatment of aqueous plastic dispersions.
CA958233A (en) Process for treating non-agricultural grounds
HK62577A (en) Basically substituted benzyl-phthalazinone derivatives, acid addition salts thereof and process for the production thereof
AU4547772A (en) Agent for the regulating of plant growth

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8127 New person/name/address of the applicant

Owner name: PERMICUTAN-KG DR. EULER, 4790 PADERBORN, DE

8139 Disposal/non-payment of the annual fee